These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4261805)

  • 21. Behçet's disease with decreased fibrinolysis and superior vena caval occlusion.
    Chajek T; Fainaru M
    Br Med J; 1973 Mar; 1(5856):782-3. PubMed ID: 4694434
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood coagulation and fibrinolytic system in Behçet's disease (author's transl)].
    Hamada T; Hosoi Y; Yoshimura R; Yamamoto S
    Nihon Hifuka Gakkai Zasshi; 1978 Sep; 88(10):615-25. PubMed ID: 309522
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fibrinolytic system of blood in patients with hypertensive disease].
    Fatkhullaev IF; Agapova LA
    Ter Arkh; 1974; 46(6):24-7. PubMed ID: 4279461
    [No Abstract]   [Full Text] [Related]  

  • 24. Antifibrinolytics gynaecology and obstetrics.
    Koutský J; Hladovec J
    Acta Univ Carol Med (Praha); 1975; 21(5-6):235-386. PubMed ID: 132853
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate).
    Bouvier CA; Berthoud S
    Helv Med Acta; 1968 Mar; 34(2):170-86. PubMed ID: 4232105
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered endogenous fibrinolysis and biochemical factors in atherosclerosis.
    Peabody RA; Tsapogas MJ; Wu KT; Deveraj KT; Karmody AM; Eckert C
    Arch Surg; 1974 Aug; 109(2):309-13. PubMed ID: 4276947
    [No Abstract]   [Full Text] [Related]  

  • 28. [Contribution to the research of fibrinolytic activity in hemorrhagic anemia].
    Pstruzinová H; Richter V; Stamidis L; Luza E
    Z Gesamte Inn Med; 1966 Mar; 21(6):183-5. PubMed ID: 5988084
    [No Abstract]   [Full Text] [Related]  

  • 29. [The biochemistry of fibrinolytic system of blood serum].
    Wolosowicz N; Jaroszewicz L; Niewiarowski S
    Postepy Biochem; 1968; 14(1):3-25. PubMed ID: 4232584
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in the area of the chemical parameters during streptokinase infusion].
    Amery A; Vermylen J; Verstraete M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):7-19. PubMed ID: 4189377
    [No Abstract]   [Full Text] [Related]  

  • 31. Gastric fibrinolysis.
    Nilsson IM; Bergentz SE; Hedner U; Kullenberg K
    Thromb Diath Haemorrh; 1975 Nov; 34(2):409-18. PubMed ID: 807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the blood fibrinolytic enzyme system of patients with cutaneous vasculitis.
    Toki N; Yamura T
    Br J Dermatol; 1980 Jul; 103(1):41-50. PubMed ID: 6775670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The preparation and evaluation of a standardized fibrin plate for the assessment of fibrinolytic activity.
    Bishop R; Ekert H; Gilchrist G; Shanbrom E; Fekete L
    Thromb Diath Haemorrh; 1970 May; 23(2):202-10. PubMed ID: 4246603
    [No Abstract]   [Full Text] [Related]  

  • 34. Depressed endogenous fibrinolytic activity in essential hypertension.
    Tsapogas MJ; Peabody RA; Wu KT; Devaraj KT; Eckert C
    J Cardiovasc Surg (Torino); 1974; 15(6):651-4. PubMed ID: 4281429
    [No Abstract]   [Full Text] [Related]  

  • 35. [Blood fibrinolytic potential during acute myocardial infarction].
    Courbier R; Jausseran JM; Forlot P; Torresani J; Henry E; Jouve A
    Presse Med (1893); 1971 Oct; 79(41):1789-92. PubMed ID: 4256155
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of growth of Walker 256 carcinosarcoma of the fibrinolytic system of the rat plasma and urine.
    Mootse G; Agostino D; Cliffton EE
    Tumori; 1970; 56(2):71-81. PubMed ID: 4248380
    [No Abstract]   [Full Text] [Related]  

  • 37. Variation in assays of standard SK and plasmin preparations: evidence for and effect of variability of plasmins, plasminogen, and fibrinogen.
    Johnson AJ; Tse A; Skoza L
    Fed Proc; 1966; 25(1):34-41. PubMed ID: 4283648
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thromboembolic complications, the coagulation and fibrinolytic blood system in heart defects with pronounced circulatory insufficiency].
    Gritsiuk AI
    Kardiologiia; 1969 Sep; 9(9):21-8. PubMed ID: 4244024
    [No Abstract]   [Full Text] [Related]  

  • 39. [Enzymatic and nonenzymatic fibrinolysis in various kidney diseases].
    Sokratov NV
    Ter Arkh; 1983; 55(6):55-8. PubMed ID: 6193598
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fibrinolytic system in patients with nephrotic syndrome].
    Andreenko GV; Poliantseva LR; Smirnova TA; Podorol'skaia LV
    Ter Arkh; 1976; 40(2):89-99. PubMed ID: 135367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.